Assessment of Adherence to Controller Inhalation Medication in Asthma- and COPD Patients.
NCT ID: NCT03791658
Last Updated: 2019-05-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
141 participants
INTERVENTIONAL
2019-01-02
2019-05-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Systemic Consequences and Comorbidities in Mild/Moderate Chronic Obstructive Pulmonary Disease (COPD), Time for Action!
NCT01314807
Monitoring Asthma and COPD in Primary Care
NCT00542061
Biannual Review of Exhaled Air and Trends in Health Evaluation in COPD
NCT07045948
Blood Eosinophil Measurements in Patients With Chronic Obstructive Pulmonary Disease
NCT03853642
Adherence to Medication and Its Impact on Chronic Obstructive Pulmonary Disease (COPD) Exacerbations: The AMICE Prospective Study
NCT01293890
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
However, studies have shown that the adherence to therapy in chronically ill patients averages around 50%. In asthma patients the level of adherence varies between 30-70%, while compliance rate in COPD patients is around 20-60% (though the numbers vary). Adherence in asthma and COPD patients is thus generally low.
Adherence in these patients is measured in studies in different ways: electronic device monitoring, dispensing data, drug levels or several self-administered questionnaires, among others. Each technique has its own benefits and drawbacks. However, the easiest to use are the self-administered questionnaires. Although many of these exist, a particularly interesting questionnaire is the TAI (Test for the Adherence to Inhalers). It exists in 2 versions: a 10-question and a longer 12-question test. The 12 question TAI has 2 added questions, in which a healthcare professional evaluates the use of the inhaler by the patient. All 12 questions can then be used to identify different non-compliance behavioural patterns. The advantages of this questionnaire are therefore that it can be used for both asthma and COPD patients, that it is designed specifically for inhalation medication and that it not only measures adherence but also the type of non-compliance .
The main aim of the study is thus to evaluate the adherence to controller inhalation medication in asthma and COPD in Universitair Ziekenhuis Brussel. Adherence will be assessed using the 12-question TAI (Test for the Adherence to Inhalers). The aim of the study is also to compare the adherence between the 2 study subgroups (asthma and COPD patients). Several other factors which could influence the compliance of the patients will also be evaluated: age, sex, pack years, FEV1, exacerbation history, symptom control, type of inhaler and number of inhalers. By identifying different patient and treatment characteristics that lead to non-adherence, future education efforts could be better targeted to these patients presenting the most important unmet need in terms of adherence.
Patient recruitment will take place at the Universitair Ziekenhuis Brussel respiratory outpatient clinic. Before their scheduled appointment, patients they will be screened to participate in the study. Recruitment will start January 2019 until March 2019, or until the target number of patients is reached. On the day of their appointment, the participants will receive all necessary information about the study and the informed consent process from the principal investigator.
Patients will have sufficient time to reflect on their participation in this study and to ask questions. After obtaining the written informed consent from the patients, the necessary interventions (filling in questionnaires and gathering information from the patients files) will take place.
It will be allowed for the patients to provide informed consent and to participate in the study on a later date.
Statistical analysis:
The statistical analysis will be conducted in 3 steps :
1. Preliminary one-way ANOVA to evaluate the dependent variable (TAI level of adherence) for each independent variable.
2. A multi-way ANOVA model will be constructed to include the relevant independent variables and potential two-way interactions, by maximization of adjusted R2 obtained through a backward elimination in order to correct for multicollinearity.
3. In a final step, the model residuals will be checked to satisfy the normality condition through application of the Kolmogorov-Smirnov and Shapiro-Wilk tests, also exploring the influence of potential heteroscedasticity.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
1 group of 70 asthmatics, 1 group of 70 COPD-patients
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Asthmatics
From the patients file the following information will be collected by the investigators:
* Age
* Sex
* FEV1 derived from the last spirometry (including spirometry performed on day of study visit).
* GINA step (Global Initiative for Asthma).
* Number of exacerbations in the year prior to the study.
* The prescribed medication: type of inhaler, number of inhalers for maintenance treatment, number of inhalations a day.
* Number of different medications taken by the patient on a daily basis, excluding the inhalers for maintenance treatment of asthma.
* FENO (Fraction Exhaled Nitric Oxide) from the day of the study visit (if available).
Patients will fill out:
* The 12-question TAI-questionnaire (test for the adherence to inhalers)
* The Asthma Control Test (ACT)
The 12-question TAI
The 12-question TAI (Test for the Adherence to Inhalers) yields a score indicating level of adherence (high, intermediate or poor). The TAI also provides some indication about the possible mechanisms of non-adherence (sporadic, deliberate or unconscious).
Information from patients file
Depending on which arm or group specific information will be gathered from the patients file after informed consent.
The Asthma Control Test (ACT)
An international validated questionnaire on the symptoms an asthmatic experiences and the disease control in the patient. Only for the Asthmatics arm of the study
COPD-patients
From the patients file the following information will be collected by the investigators:
* Age
* Sex
* Pack Years
* GOLD stage (Global Initiative for Chronic Obstructive Lung Disease)(post-bronchodilator FEV1)
* Number of exacerbations in the year prior to the study.
* The prescribed medication: type of inhaler, number of inhalers for maintenance treatment, number of inhalations a day.
* Number of different medications taken by the patient on a daily basis, excluding the inhalers for maintenance treatment of COPD.
Patients will fill out:
* The 12-question TAI-questionnaire (test for the adherence to inhalers)
* The COPD Assessment Test (CAT)
The 12-question TAI
The 12-question TAI (Test for the Adherence to Inhalers) yields a score indicating level of adherence (high, intermediate or poor). The TAI also provides some indication about the possible mechanisms of non-adherence (sporadic, deliberate or unconscious).
Information from patients file
Depending on which arm or group specific information will be gathered from the patients file after informed consent.
The COPD Assessment Test (CAT)
An international validated questionnaire on the symptoms a COPD-patient experiences and the disease control in the patient. Only for the COPD arm of the study
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
The 12-question TAI
The 12-question TAI (Test for the Adherence to Inhalers) yields a score indicating level of adherence (high, intermediate or poor). The TAI also provides some indication about the possible mechanisms of non-adherence (sporadic, deliberate or unconscious).
Information from patients file
Depending on which arm or group specific information will be gathered from the patients file after informed consent.
The Asthma Control Test (ACT)
An international validated questionnaire on the symptoms an asthmatic experiences and the disease control in the patient. Only for the Asthmatics arm of the study
The COPD Assessment Test (CAT)
An international validated questionnaire on the symptoms a COPD-patient experiences and the disease control in the patient. Only for the COPD arm of the study
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* COPD-patients , GOLD stage II-IV.
Exclusion Criteria
* COPD patients not on long-acting bronchodilators.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universitair Ziekenhuis Brussel
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lisa Nicky Vancampenhout
Medical student
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lisa N Vancampenhout
Role: PRINCIPAL_INVESTIGATOR
Master student in Medicine at Vrije Universiteit Brussel
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universitair Ziekenhuis Brussel
Brussels, Brussels Capital, Belgium
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Plaza V, Fernandez-Rodriguez C, Melero C, Cosio BG, Entrenas LM, de Llano LP, Gutierrez-Pereyra F, Tarragona E, Palomino R, Lopez-Vina A; TAI Study Group. Validation of the 'Test of the Adherence to Inhalers' (TAI) for Asthma and COPD Patients. J Aerosol Med Pulm Drug Deliv. 2016 Apr;29(2):142-52. doi: 10.1089/jamp.2015.1212. Epub 2015 Jul 31.
Related Links
Access external resources that provide additional context or updates about the study.
The Asthma Control Test used in this study
The COPD Assessment Test used in this study
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PNE 2018-386
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.